#1 Clinical Trials Search in Europe

Insulin Human

This article examines several clinical trials investigating the use of human insulin in managing diabetes. These studies aim to evaluate the effectiveness, safety, and pharmacodynamic properties of various insulin formulations and administration methods. The trials focus on different aspects of insulin therapy, including its use in type 1 and type 2 diabetes, perioperative glucose management, and comparisons between different insulin types and delivery methods.

Table of Contents

What is Insulin Human?

Insulin Human is a medication used to manage blood sugar levels in people with diabetes. It is a synthetic version of the insulin naturally produced by the human body. Insulin Human is also known by other names such as regular human insulin or Humulin R[1]. This medication helps your body use glucose (sugar) for energy and prevents your blood sugar from getting too high.

Uses and Conditions Treated

Insulin Human is primarily used to treat Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus. These are conditions where your body either doesn’t produce enough insulin (Type 1) or doesn’t use insulin effectively (Type 2), leading to high blood sugar levels[1][5]. By using Insulin Human, patients can better control their blood sugar levels and manage their diabetes.

Types and Formulations

Insulin Human comes in different types and formulations to suit various patient needs:

  • Regular Human Insulin: This is a short-acting insulin that starts working quickly after injection[1].
  • Non-preserved (NP) formulation: A special form of regular human insulin that may be combined with other substances to enhance its effectiveness[1].
  • Premixed Insulin: A combination of different types of insulin in one injection, which can provide both immediate and longer-lasting blood sugar control[5].

Administration and Dosing

Insulin Human is typically administered through subcutaneous (under the skin) injections. The dosing and frequency can vary depending on the specific formulation and individual patient needs:

  • Regular Human Insulin: Often injected before meals to control blood sugar spikes after eating[1].
  • Premixed Insulin: May be given once or twice daily, usually before breakfast and dinner[5].
  • Implantable Insulin: In some cases, Insulin Human may be administered through an implantable pump system for continuous delivery[3].

The exact dosing is determined by your healthcare provider based on factors such as your blood sugar levels, weight, and lifestyle[5].

Effectiveness and Benefits

Insulin Human has been shown to be effective in managing blood sugar levels in people with diabetes. Some of the key benefits include:

  • Improved Glycemic Control: Helps achieve target HbA1c levels (a measure of average blood sugar over 2-3 months)[5].
  • Flexibility: Different formulations allow for tailored treatment plans to suit individual needs[1][5].
  • Reduced Complications: Proper use can help prevent or delay diabetes-related complications by maintaining good blood sugar control[5].

Safety and Side Effects

While Insulin Human is generally safe and effective when used as prescribed, it can have some side effects:

  • Hypoglycemia: Low blood sugar is the most common side effect. Symptoms can include shakiness, sweating, confusion, and in severe cases, loss of consciousness[1][5].
  • Weight Gain: Some patients may experience weight gain when starting insulin therapy[5].
  • Injection Site Reactions: Redness, swelling, or itching at the injection site can occur[1].

It’s important to monitor your blood sugar levels regularly and follow your healthcare provider’s instructions carefully to minimize these risks[5].

Comparisons with Other Insulins

Insulin Human is often compared to other types of insulin in clinical studies:

  • Insulin Glargine: A long-acting insulin that may provide more stable blood sugar control over 24 hours compared to regular human insulin[5].
  • Insulin Lispro: A rapid-acting insulin that may work more quickly than regular human insulin[1].
  • Insulin Degludec: An ultra-long-acting insulin that may offer more flexibility in dosing time compared to regular human insulin[4].

Your healthcare provider will consider various factors when choosing the best insulin regimen for you, including your lifestyle, blood sugar patterns, and personal preferences[5][4].

Aspect Details
Types of Diabetes Studied Type 1 and Type 2 diabetes
Insulin Formulations Regular human insulin, insulin lispro, premixed insulins, basal insulins, rapid-acting insulins, VIAject
Administration Methods Subcutaneous injections, intravenous infusions, basal-bolus regimens, premixed regimens
Key Outcome Measures Blood glucose levels, HbA1c, hypoglycemic events, insulin sensitivity, post-meal glucose control
Special Populations Patients with end-stage renal disease, perioperative patients
Novel Approaches Comparison of insulin types, evaluation of educational interventions, assessment of glucose monitoring techniques

FAQ

  • What types of diabetes are being studied in these clinical trials? The clinical trials are studying both type 1 and type 2 diabetes. Some trials specifically focus on type 1 diabetes patients, while others include patients with type 2 diabetes or both types.
  • What are some of the insulin formulations being investigated? The trials are investigating various insulin formulations, including regular human insulin (RHI), insulin lispro, premixed insulin (such as Humulin 30/70), basal insulins (like Humulin N), and rapid-acting insulins (like Humulin R). Some studies also examine newer formulations like VIAject.
  • How is insulin administration being studied in these trials? The trials are exploring different methods of insulin administration, including subcutaneous injections, intravenous infusions, and comparisons between basal-bolus regimens and premixed insulin regimens. Some studies also look at the timing of insulin administration in relation to meals.
  • What are the main outcomes being measured in these studies? The main outcomes being measured include changes in blood glucose levels, HbA1c levels, frequency of hypoglycemic events, insulin sensitivity, and the effectiveness of different insulin regimens in controlling post-meal glucose excursions. Some studies also assess quality of life and the impact of educational interventions.
  • Are there any special patient populations being studied? Yes, some trials focus on specific patient populations. For example, one study examines insulin management in patients with end-stage renal disease (ESRD) undergoing surgery, comparing them to diabetic patients without kidney disease.

Ongoing Clinical Trials on Insulin Human

  • Study on the Safety of ELGN-2112 for Preterm Infants with Intestinal Malabsorption

    Recruiting

    3 1
    Investigated drugs:
    Austria France Italy The Netherlands Spain Sweden

  • Study of intranasal insulin to prevent delirium in patients aged 65 years or older following elective cardiac surgery

    Recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on Insulin Eye Drops for Treating Persistent Corneal Epithelial Defect in Patients with Neurotrophic or Chronic Ocular Surface Diseases

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on the Effects of ELGN-2112 (Human Insulin) for Treating Intestinal Malabsorption in Preterm Infants

    Recruiting

    3 1
    Investigated drugs:
    Austria France Italy The Netherlands Spain Sweden

  • Study of Insulin Treatment for Blood Glucose Control in Adult Critically Ill Patients with Stress Hyperglycemia

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Belgium

  • Study on Insulin Eye Drops for Treating Dry Eye in Patients Using Topical Hypotensors

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on the Effectiveness and Safety of Insulin, Ciclosporin, and Benzalkonium Chloride in Patients with Moderate to Severe Dry Eye Disease

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

Glossary

  • HbA1c: Hemoglobin A1c, a blood test that measures average blood sugar levels over the past 2-3 months. It's used to diagnose diabetes and monitor long-term blood sugar control.
  • Hypoglycemia: A condition where blood sugar levels drop below normal, potentially causing symptoms like shakiness, confusion, and in severe cases, loss of consciousness.
  • Basal-bolus insulin regimen: An insulin therapy approach that mimics the body's natural insulin release, using long-acting insulin for background (basal) needs and rapid-acting insulin for meal-time (bolus) needs.
  • Endogenous glucose production: The natural production of glucose by the body, primarily by the liver, to maintain blood sugar levels between meals and during fasting.
  • Insulin sensitivity: The body's responsiveness to insulin, indicating how effectively cells can use glucose from the bloodstream in response to insulin.
  • Pharmacodynamics: The study of how a drug affects the body, including its mechanism of action, the relationship between drug concentration and effect, and the time course of its effect.
  • Glucose clamp: A research technique used to measure insulin sensitivity by maintaining a constant blood glucose level while infusing glucose and insulin.
  • Continuous Glucose Monitoring System (CGMS): A device that measures glucose levels in the interstitial fluid continuously throughout the day and night, providing a more comprehensive view of glucose trends.

References

  1. https://clinicaltrials.gov/study/NCT00883558
  2. https://clinicaltrials.gov/study/NCT02401243
  3. https://clinicaltrials.gov/study/NCT01194882
  4. https://clinicaltrials.gov/study/NCT03668808
  5. https://clinicaltrials.gov/study/NCT01121835